Published on 17/12/2025
Medical Device Classification and Registration under DIGEMID
The classification and registration of medical devices in Peru is governed by the General Directorate of Medicine and Medical Devices (DIGEMID), an entity under the Ministry of Health. It is crucial for companies aiming to market their devices in Peru to understand the specific regulatory compliance requirements mandated by DIGEMID. This article serves as a step-by-step tutorial guide for pharmaceutical regulatory compliance professionals navigating the complexities of medical device registration in Peru.
Step 1: Understanding Medical Device Classification
Medical devices in Peru are classified based on their risk levels, which informs the regulatory pathway they must follow. DIGEMID employs a four-tier classification system: Class I, Class II, Class III, and Class IV. Each of these classifications corresponds to the risk associated with their intended use.
- Class I: These devices represent the lowest risk and are generally subject to the fewest regulatory controls. Examples include bandages and surgical instruments.
- Class II: Contain moderate risks, often requiring a more robust regulatory oversight. Examples are infusion pumps and hearing aids.
- Class III: Associated with
The classification is mainly determined by factors such as the duration of use, the invasiveness of the device, and the intended purpose. It is essential to provide adequate documentation regarding the classification rationale during the registration process.
To streamline this process, companies should conduct thorough research into the types and specifications of medical devices they aim to market. Utilizing resources such as the DIGEMID website can provide critical insights into classification criteria and examples of already classified devices.
Step 2: Dossier Preparation for Registration
The next critical step is to prepare the regulatory dossier for submission to DIGEMID. A comprehensive dossier is central to achieving successful medical device registration, requiring a meticulous collection of predefined documents and information.
The essential components of a medical device registration dossier in Peru include:
- Device description: This should detail the intended use, operating principles, and design specifications.
- Quality Management System (QMS) documentation: Companies must provide proof of compliance with ISO 13485 or Peruvian equivalent guidelines.
- Clinical Evidence: Depending on the classification, clinical data supporting the safety and efficacy may be required. This should include clinical trial results or comparative data from similar marketed devices.
- Labeling and Instructions for Use: Labels must comply with local regulations, including language requirements and essential warnings.
Compilation of the dossier requires cross-functional collaboration among regulatory, clinical, quality, and manufacturing teams to ensure completeness and accuracy. This may involve gathering supporting documents such as risk management reports, ethical approvals, and manufacturing information.
Moreover, it is recommended to refer to the DIGEMID’s guidelines to ensure all technical requirements are met. Proactively addressing potential queries that might arise during dossier evaluation can significantly expedite the approval timeline.
Step 3: Submission of the Dossier to DIGEMID
Once the dossier is prepared, the next phase is submission. Companies must submit their dossier to DIGEMID in accordance with the established procedures. The submission process includes several key steps that must be meticulously followed to avoid delays in approval.
Firstly, firms must complete and sign a registration application form, which includes identification details and a declaration of compliance with applicable regulatory standards.
After completing the application, companies must submit the dossier physically or electronically via the DIGEMID’s official channels. It is advisable to retain copies of all submitted documents for accountability and tracking purposes.
In conjunction with the dossier submission, companies may also need to complete a payment process relevant to the registration fees outlined by DIGEMID.
It is imperative to establish a timeline for submission and monitor the regulatory process closely. Understanding the expected turnaround time will aid in subsequent strategies, particularly if additional data or clarification is requested by DIGEMID. Ensure that all communications are documented and that responses to any queries from regulators are timely and comprehensive.
Step 4: Review Process by DIGEMID
After submission, the dossier enters a review phase by DIGEMID. This step can significantly influence the overall timeline for approval. The review process is designed to ensure that medical devices meet safety and efficacy standards according to Peruvian regulations.
DIGEMID evaluates the dossier against various criteria, including:
- Compliance with device classification standards
- Completeness and accuracy of submitted technical documentation
- Robustness of clinical evidence
- Conformity with local labeling requirements
During this evaluation phase, DIGEMID may require additional information or clarification regarding specific aspects of the submission. Companies should be prepared to respond to these requests quickly, providing documented rationale and supplementary data as necessary.
It is also beneficial to establish a direct communication line with the regulatory contact at DIGEMID for any clarifications during the review process. This proactive approach can further streamline the resolution of any queries and mitigate possible delays in approval.
Step 5: Receiving Approval and Post-Approval Steps
Upon successful completion of the review, DIGEMID issues a registration certificate allowing the marketing of the device in Peru. This is a pivotal moment in the regulatory journey, marking the transition to market entry.
However, obtaining approval is not the end of the regulatory obligations. Medical device manufacturers are expected to comply with ongoing responsibilities related to post-market surveillance and vigilance. Some key considerations include:
- Pharmacovigilance: Establish a system to monitor the safety of the device once on the market, including reporting adverse events as required by the regulations.
- Quality System Compliance: Maintain adherence to the established QMS, including regular audits and inspections.
- Recalls and Field Safety Notices: Prepare a plan for swift action in case safety issues arise, including communication strategies to notify affected parties.
Additionally, it is essential to remain cognizant of any changes in regulatory frameworks. Engaging with industry associations or subscribing to regulatory updates can enhance a company’s foresight regarding impending changes in DIGEMID regulations.
Step 6: Importance of Continuous Regulatory Compliance
Maintaining pharma regulatory compliance throughout the lifecycle of a medical device is critical. Continuous compliance not only ensures the safety and effectiveness of devices but also fosters trust among healthcare professionals and patients.
Companies must invest in training programs for regulatory personnel to stay current with best practices and changes in regulations. Regular internal audits can help identify potential areas of non-compliance before they escalate into regulatory issues.
Organizations should also consider forming partnerships with regulatory consultants who specialize in regional compliance issues. Such collaborations can provide insights into nuances in regulatory practices and enhance the efficacy of compliance strategies.
In conclusion, navigating the requirements for medical device classification and registration under DIGEMID is a multifaceted process that necessitates attention to detail, planning, and proactive engagement with the regulatory authorities. By following the outlined steps and fostering a culture of compliance, companies can effectively market their medical devices in Peru while ensuring the safety and well-being of patients.